PRESS
Read the press release (german version)
Further information : Prof. Bruno Domon's speech and the Press conference invitation .
Complix is focused on the discovery and development of next generation drugs based on “Alphabodies”, a novel class of biopharmaceuticals with superior therapeutic potential. Complix also announced the creation of a fully-owned subsidiary in Luxembourg to develop novel Alphabody based therapies against viral diseases in a strategic collaboration with CRP-Santé.
Download the Local Press release:
Download the International Press release:
The presentation was organized at the Clinique d’Eich – Fondation Norbert Metz and has gathered more than 100 persons.
Read the invitation
Read the Press release
She sees this new project as a true challenge: developing a growing and promising research unit, managing a team as well as numerous clinical research projects in the field of oncology, nutrition or cardiology.
Read the Press release about Anna CHIOTI - French Version
